Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.

Slides:



Advertisements
Similar presentations
Rational Drug Use Supported by USAID Prescribing, Dispensing, Counseling and Adherence in ART Programs.
Advertisements

ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Antiretrovirals in Children.
Version 11Page 1 of 6 Improving Identification of Patients Infected with HIV Using Rapid Testing in the Emergency Department: A Systems-Based Approach.
Dental Management of the Patient With HIV/AIDS; Current Concepts: 2002 Introduction Pennsylvania Mid-Atlantic AIDS Education and Training Center Introduction.
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
BHIVA Service Commissioning Survey – 2014 Tuesday 4 November 2014.
Offering ARV Treatment to All HIV-infected Persons in San Francisco Grant Colfax, MD Director of HIV Prevention and Research San Francisco Department of.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Changing Therapy Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents published October 2006 AETC NRC Slide Set.
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria.
Slide 1 of 11 From CB Hicks, MD, at Chicago, IL: May 20, 2013, IAS-USA. IAS–USA Charles B. Hicks, MD Professor of Medicine Duke University Medical Center.
6/28/00TPED1 Resistance Testing: What is it? What does it mean? How does drug resistance emerge? Overview of methods Advantages and disadvantages Current.
Cost-effectiveness of different starting criteria of antiretroviral therapy in Mexico. Caro Y., Colchero A., Valencia A., Bautista-Arredondo S., Sierra.
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT) Implications.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Feedback from Pregnancy research group UK CHIC / UK HIV Drug Resistance Database Meeting, 2 July 2010 Pregnancy Group: Jane Anderson, Loveleen Bansi, Susie.
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
Africans and HIV in the UK: an epidemiological perspective Nov 2006 Tim Chadborn On behalf of the HIV Reporting Section with special thanks to Julia Abernethy.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
What do models estimate to be the impacts on HIV incidence of various percentages of people with HIV on ART ? National AIDS Trust Treatment as Prevention.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Future ART options for HIV-infected children exposed to maternal HAART Lee Kleynhans Experts Roundtable June 2008.
Immigration Removal Centres and HIV Joe Murray Policy Officer National AIDS Trust.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
BHIVA Audit Survey of patient assessment and monitoring Set-up phase of cohort audit of patients starting ART from naïve.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Guidelines for the use of antiretroviral agents in HIV infections in Taiwan, revised in 2002 by Infectious Diseases Society of the ROC and Taiwan AIDS.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.
I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Prevention of Mother to Child HIV Transmission Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation July 15, 2009 Cape.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
The Effectiveness of generic Highly Active Antiretroviral Therapy for the treatment of HIV infected Ugandan children Presenter: Linda Barlow-Mosha MD,
Provider initiated testing in Kenya Ruth Nduati Associate Prof Paediatrics University of Nairobi.
ANTEPARTUM CARE. Pregnant Women Who Are ARV Naive (1)  Pregnant women with HIV infection should receive standard clinical, immunologic, and virologic.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Martin Fisher Foundation: 14 September Remembering Martin Fisher Simon Collins, HIV i-Base Who should get tested? How and why should.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.
Atazanavir Use in Pregnancy : a report of 33 cases St George’s Hospital South West London HIV & GUM Clinical Services Network Macky Natha 1, Phillip Hay.
1 Assisting PLWHAs Returning to Mexico and other Latin American Countries: A Pilot Project Oscar Gonzalez, PhD Texas/Oklahoma AETC Tracy Tessmann, MA Texas/Oklahoma.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System Predictors for high viraemia among the treatment naïve population.
1 WHEN TO START TREATMENT. Early success: Improving outcomes with ART, Adapted from Moore R et al. 11 th Conference on Retroviruses and Opportunistic.
Cost-effectiveness of initiating and monitoring HAART based on WHO versus US DHHS guidelines in the developing world Peter Mazonson, MD, MBA Arthi Vijayaraghavan,
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Provider Initiated HIV Counseling and Testing Unit 1: Introduction to HIV/AIDS.
Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.
Update on Breastfeeding and HIV studies
Antiretroviral Therapy (ART) for HIV Prevention:
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Utilizing research as an opportunity to strengthen
The use of cotrimoxazole prophylaxis in the context of HIV infection
THE AFRICAN EYE TRUST HIV/AIDS in 2007: A Complex Picture
Charles Gilks HIV Department, WHO
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust

Background Many asylum applicants come from countries with high background rates of HIV HIV is rarely seen as a legal reason to remain in the UK Access to HIV care is unequal and problematic Stigma impacts on disclosure

National AIDS Trust Survey Questionnaire survey of health care managers in 10 IRC 2005/6 159 detainees known to be HIV positive 140 diagnosed before detention 28 pregnant women 91 on ARVS

What can HIV Therapy offer in 2008? Improved quality of life Less HIV-related morbidity and mortality Restoration and/or preservation of immune function Maximal and durable suppression of HIV viral load Prevention of vertical transmission Prevention of transmission to sexual partners Preservation of future treatment options 1/08

Current Antiretroviral Medications 1/08 Atripla

“We believe that every person with HIV is entitled to a uniformly high standard of medical care. These standards are therefore applicable to the care of all adults living with HIV in the UK.”

“The new paradigm should be aiming for an undetectable and durable HIV plasma viral load suppression, wherever possible, leading to immunological improvement with lack of clinical progression and improvement in quality of life” Gazzard et al. BHIVA guidelines for the treatment of HIV-infected adults with antiretroviral therapy HIV Med Nov;7(8):

Circulatin g drug Viral replication Resistance

Inadequat e levels of drug Personal factors Toxicity Low potency Wrong dose Poor absorption Rapid clearance inadequate activation Drug Interactions Structural factors Intermittent dosing

Stopping drugs with different half-lives 0 Time (hours) Drug concentration Zone of potential replication Based on Taylor S et al. CROI 2004 Abs 131 Functional monotherapy Last dose

Basic Information How long has the HIV diagnosis been known? What is the nadir CD4 count? What is the most recent CD4 count? Higher risk if either is below 200 cells/mm 3 Is the patient on antiretroviral drugs? Primary or secondary prophylaxis?

Is the patient sick? How long has the HIV diagnosis been known? Thorough history and examination Remember unusual things are less unusual Usual things may look un - usual Could this be iatrogenic?

ARVs Is the patient on antiretrovirals? Are the drugs with the patient? Which ones? For how long? Stable? Effective? Has the patient been assessed by the local HIV clinic?

Who knows what? What's been happening in the IRC? Newly diagnosed? Data from the usual treating clinicians Data from local HIV treating clinicians NGO involvement

How IRCs should support those living with HIV during detention and the removal process How can NHS HIV specialist clinicians best work with IRCs? Access to high-quality clinical primary care services and secondary care with expertise in HIV and associated specialties Appropriate clinical handover to ensure continuity of care HIV testing (diagnosis for those infected) and prevention (for those uninfected) BHIVA/NAT project

Useful Resources British HIV Association (BHIVA) British Association of Sexual Health and HIV (BASHH). National AIDS Trust (NAT) Terrence Higgins Trust (THT) International HIV/AIDS Alliance